Back to search
FDAFDA · Food and drugs·Recall number Z-1993-2013

Cardiogenesis Corporation - Cardiogenesis Transmyocardial Laser. The device is indicated for use in the treatment of patients with angina (Canadian Cardiovascular Society Class 4) refractory to medical treatment and secondary to objectively demonstrated coronary artery atherosclerosis and with a region of the myocardium with reversible ischemia not amenable to direct coronary revascularization.

Published September 18, 2013 · Recall initiated: May 1, 2011

Summary

FDA records medical device Class II recall Z-1993-2013, published September 18, 2013 and initiated May 1, 2011. Recalling firm: Cardiogenesis Corporation; Status: Terminated; Reported quantity: 2498; Lot: Product Code - HP-SG3 Product Code -HP-PRL5. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Following acquisition of Cardiogenesis, we began receiving complaints of sparks, burns, or smoke incidents related to the handpieces.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Cardiogenesis Corporation
Distributor
US Distribution
Lot
Product Code - HP-SG3 Product Code -HP-PRL5
Risk classification
Class II
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was Cardiogenesis Corporation - Cardiogenesis Transmyocardial Laser. The device is indicated for use in the treatment of patients with angina (Canadian Cardiovascular Society Class 4) refractory to medical treatment and secondary to objectively demonstrated coronary artery atherosclerosis and with a region of the myocardium with reversible ischemia not amenable to direct coronary revascularization. recalled?

Yes. FDA published recall Z-1993-2013 on September 18, 2013. Reported hazard: Following acquisition of Cardiogenesis, we began receiving complaints of sparks, burns, or smoke incidents related to the handpieces.

What should I do if I have this product?

Voluntary: Firm initiated · Letter